GALERA LABS, LLC;BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
KEENE, JEFFERY L.,RILEY, DENNIS P.,BEARDSLEY, ROBERT A.,STORY, MICHAEL DEAN,MAPUSKAR, KRANTI ASHOK,SPITZ, JR., DOUGLAS R.,ALLEN, BRYAN G.,DAVIS, ANDREW BLAKE,ZEPEDA OROZCO, DIANA
申请号：
CA3090129
公开号：
CA3090129A1
申请日:
2019.01.31
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
A method of treating a cancer in a mammalian subject afflicted with the cancer, consisting essentially of administering to the subject a therapeutically effective amount of a platinum-based anticancer agent, and administering to the subject a therapeutically effective amount of a pentaaza macrocyclic ring complex corresponding to the Formula (I) below, prior to, concomitantly with, or after administration of the platinum-based anticancer agent, whereby response of the cancer to the platinum-based anticancer agent is increased.
